Rocket Doctor AI【AIDR】銘柄情報

Rocket Doctor AI Inc (AIDR) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.60

( -1.64% )

買値

0.59

売値

0.62

出来高

204,185

0.57 日の範囲 0.62

0.52 52 週間の範囲 0.98

時価総額

58.167M

前日終値

0.61

始値

0.62

時刻

1500

0.6

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

$ 186,095

発行済株式数

96,944,706

配当利回り

PER

-3.62

1 株当たり利益 (EPS)

-0.17

歳入

38.14k

純利益

-2.01M

Rocket Doctor AI Inc. provides personalized health care information services in Canada and United States. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an ass... Rocket Doctor AI Inc. provides personalized health care information services in Canada and United States. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. 詳細を表示

セクター

Healthcare

業界

Healthcare Providers & Services

ウェブサイト

www.treatment.com

本社

Vancouver, Canada

設立

2026

Rocket Doctor AI Inc is listed in the Healthcare sector of the Canadian Securities Exchange with ticker AIDR. The last closing price for Rocket Doctor AI was $0.61. Over the last year, Rocket Doctor AI shares have traded in a share price range of $ 0.52 to $ 0.98.

Rocket Doctor AI currently has 96,944,706 shares in issue. The market capitalisation of Rocket Doctor AI is $58.17 million. Rocket Doctor AI has a price to earnings ratio (PE ratio) of -3.62.

Rocket Doctor Partners with Mindstride to Expand Access to After-Hours Healthcare Across Ontario, Alberta and British Columbia

Rocket Doctor has partnered with Mindstride AI to provide after-hours and overflow physician coverage, with...

Rocket Doctor Takes Center Stage in Inaugural NASCAR Cup Series Race at Naval Base Coronado as Primary Partner of Rick Ware Racing

The inaugural NASCAR Cup Series race at Naval Base Coronado in San Diego marks the first of 50 planned...

Rocket Doctor AI Subsidiary Treatment.com Secures Year 2 NIH Funding to Advance AI-Powered Family Health History Tool

The National Institute on Minority Health and Health Disparities (NIH) has confirmed Year 2 funding for the...

Rocket Doctor Grants Stock Options and RSUs

Vancouver, BC, June 12, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt:...

Rocket Doctor AI Launches a Strategic Marketing Partnership with Rick Ware Racing and FINTEKK AP for the 2026 NASCAR Cup Series, NHRA (National Hot Rod Association), World Supercross Championship, AFT (AMA - American Flat Track) and other Nationally te

Rocket Doctor AI launches a strategic marketing partnership with Rick Ware Racing and FINTEKK AP to accelerate...

Rocket Doctor AI Announces Strong Q1 Momentum Driven by U.S. Expansion, New Payer Contracts and Platform Growth

Continued organic quarter over quarter revenue growth to $737KEarnings per share for Q1, 2026: ($0.05) per...

Rocket Doctor AI Announces Global Company Town Hall to Showcase 2025 Milestones; Q1 2026 Milestones and Strategic Vision

Vancouver, BC, May 27, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939...

Rocket Doctor Enters into North Star Agreement

Vancouver, BC, May 19, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939...

Rocket Doctor and University of Toronto Launch Digital Health Observership Program for Physician Assistant Students

First clinic launched April 14, 2026, supporting first-year Physician Assistant observership requirements at...

Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI Innovation

Continued organic quarter over quarter revenue growth with growth of over 30% from Q3 to Q4 2025 (from $529,123...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.04	-6.25	0.64	0.65	0.57	55764	0.61578131	CS
4	-0.02	-3.22580645161	0.62	0.72	0.56	163943	0.65248759	CS
12	0.04	7.14285714286	0.56	0.72	0.54	191934	0.61900502	CS
26	-0.15	-20	0.75	0.84	0.52	201214	0.67373738	CS
52	0.06	11.1111111111	0.54	0.98	0.52	201720	0.71582811	CS
156	0.06	11.1111111111	0.54	0.98	0.52	201720	0.71582811	CS
260	0.06	11.1111111111	0.54	0.98	0.52	201720	0.71582811	CS